Contrast-enhanced MRI in Children 2 Months to <2 Years

Status:
Completed

Trial end date:
2010-09-01

Target enrollment:

Participant gender:

The purpose of this study is to determine pharmacokinetics, safety and efficacy of Magnevist in children 2 months to < 2 years of age

Phase 3

Bayer